Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Using points for low value items can waste your rewards. Discover smarter choices to make the most of your credit card benefits.
24,708 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As earnings season unfolds, SPIR investors want clarity on the drivers behind spire (spir) 2026 earnings. This guide ...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
Patience and big-capital bets define Iren's path. This analysis explains why Iren's earnings highlight long-term grow...
Rumors around PayPal buyouts grab headlines and move markets. Here’s how to separate signal from noise, evaluate pote...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...